Articles by Chris
-
Reimagining the Future of Cancer Care, Together
Reimagining the Future of Cancer Care, Together
By Chris Boshoff, MD, PhD, FMedSci
-
Science Will Win Against Multiple Myeloma
Science Will Win Against Multiple Myeloma
By Chris Boshoff, MD, PhD, FMedSci
-
Peeking into 2023 for Oncology & Rare Diseases
Peeking into 2023 for Oncology & Rare Diseases
By Chris Boshoff, MD, PhD, FMedSci
Activity
-
Earlier this year, Suneet Varma, President, Pfizer Oncology Commercial, informed me of his decision to retire from Pfizer by early 2025. Joining…
Earlier this year, Suneet Varma, President, Pfizer Oncology Commercial, informed me of his decision to retire from Pfizer by early 2025. Joining…
Shared by Chris Boshoff, MD, PhD, FMedSci
Experience & Education
More activity by Chris
-
It was my great pleasure to participate in STAT’s “Pathways to Progress” event live from #ASCO24, where I had the opportunity to share more about…
It was my great pleasure to participate in STAT’s “Pathways to Progress” event live from #ASCO24, where I had the opportunity to share more about…
Shared by Chris Boshoff, MD, PhD, FMedSci
-
In our 175th year, we’re proud to continue Pfizer’s legacy at the forefront of scientific innovation with this recognition as one of TIME's 100 Most…
In our 175th year, we’re proud to continue Pfizer’s legacy at the forefront of scientific innovation with this recognition as one of TIME's 100 Most…
Shared by Chris Boshoff, MD, PhD, FMedSci
-
Breakthrough science requires innovative thinking and a commitment to advancing new avenues of research. I’m honored to see two close colleagues on…
Breakthrough science requires innovative thinking and a commitment to advancing new avenues of research. I’m honored to see two close colleagues on…
Shared by Chris Boshoff, MD, PhD, FMedSci
-
Backed by decades of development, we’re seeing a renaissance in antibody-drug conjugate (#ADC) therapies that could help deliver new, highly targeted…
Backed by decades of development, we’re seeing a renaissance in antibody-drug conjugate (#ADC) therapies that could help deliver new, highly targeted…
Shared by Chris Boshoff, MD, PhD, FMedSci
-
Today, Albert Bourla accepted an award during #AACR24 in recognition of our commitment to driving scientific innovation to improve the lives of…
Today, Albert Bourla accepted an award during #AACR24 in recognition of our commitment to driving scientific innovation to improve the lives of…
Shared by Chris Boshoff, MD, PhD, FMedSci
-
This month is both Myeloma Action Month & Colorectal Cancer Awareness Month, and we're elevating the needs of those impacted by both of these…
This month is both Myeloma Action Month & Colorectal Cancer Awareness Month, and we're elevating the needs of those impacted by both of these…
Shared by Chris Boshoff, MD, PhD, FMedSci
-
2023 was a tremendous year for our Pfizer Oncology team as we welcomed our new Seagen colleagues, combining our technologies and expanding our scale.…
2023 was a tremendous year for our Pfizer Oncology team as we welcomed our new Seagen colleagues, combining our technologies and expanding our scale.…
Shared by Chris Boshoff, MD, PhD, FMedSci
-
Last week, we had the privilege of sharing more about our new Pfizer Oncology organization at our first-ever Oncology Innovation Day with the…
Last week, we had the privilege of sharing more about our new Pfizer Oncology organization at our first-ever Oncology Innovation Day with the…
Shared by Chris Boshoff, MD, PhD, FMedSci
Other similar profiles
Explore collaborative articles
We’re unlocking community knowledge in a new way. Experts add insights directly into each article, started with the help of AI.
Explore More